RT @doctorRBC: Tofactinib efficacy for treatment of ankylosing spondylitis comparable across different BMI's. Regardless
Tweet Content
Tofactinib efficacy for treatment of ankylosing spondylitis comparable across different BMI's. Regardless of BMI, tofacitinib better than placebo.
BMI <25: more AE and SAE
Abs#0405 @RheumNow #ACR22 https://t.co/qs3U4mjUXD
Show on Archive Page
On
Display in Search Results
On
PDQ
Off